Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Quince Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −9 vs. Q2 2024
- Shares held
- 5.19M
- −699.1K (−11.9%) vs. Q2 2024
- Total value
- $4.04M
- −$374.0K (−8.5%) vs. Q2 2024
- New holders
- 3
- 10 more added
- Sold out
- 12
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Westside Investment Management, Inc. | 75 | $58 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 100 | $78 | 0.00% | 00.0% | Unchanged |
| Financial Avengers, Inc. | 100 | $78 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $216 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 295 | $229 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $241 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $264 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 431 | $335 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 480 | $373 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 548 | $425 | 0.00% | +79+16.8% | Added |
| Tower Research Capital LLC (TRC) | 5,549 | $4.31K | 0.00% | −4,069−42.3% | Reduced |
| Morgan Stanley | 8,522 | $6.62K | 0.00% | 00.0% | Unchanged |
| Nixon Peabody Trust Co | 11,126 | $8.64K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 17,127 | $13.3K | 0.00% | +11,962+231.6% | Added |
| XTX Topco Ltd | 21,570 | $16.7K | 0.00% | +7,493+53.2% | Added |
| Susquehanna International Group, LLP | 32,553 | $25.3K | 0.00% | −66,050−67.0% | Reduced |
| Northern Trust Corp | 34,023 | $26.4K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 53,527 | $41.5K | 0.01% | +215+0.4% | Added |
| State Street Corp | 56,611 | $43.9K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 88,495 | $68.7K | 0.00% | −50,000−36.1% | Reduced |
| Citadel Advisors LLC | 107,007 | $83.1K | 0.00% | +7,163+7.2% | Added |
| Mariner, LLC | 122,461 | $95.1K | 0.00% | +48,387+65.3% | Added |
| ADAR1 Capital Management, LLC | 142,958 | $111.0K | 0.02% | +50,000+53.8% | Added |
| Bank of America Corp | 157,978 | $122.6K | 0.00% | +60.0% | Added |
| Shay Capital LLC | 172,183 | $133.6K | 0.04% | +172,183 | New |
| Alphabet Inc. | 189,122 | $147.5K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 339,125 | $263.3K | 0.00% | +66,170+24.2% | Added |
| HighTower Advisors, LLC | 341,570 | $273.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 358,358 | $278.2K | 0.00% | +358,358 | New |
| Almitas Capital LLC | 382,882 | $297.2K | 0.11% | +382,882 | New |
| Renaissance Technologies LLC | 522,576 | $405.6K | 0.00% | +38,674+8.0% | Added |
| EPIQ Capital Group, LLC | 825,942 | $641.1K | 0.18% | −26,419−3.1% | Reduced |
| Vanguard Group Inc | 1,199,648 | $930.9K | 0.00% | −14,973−1.2% | Reduced |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −93,600−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −36,567−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −15,359−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −11,013−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −10,136−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | 0 | $0 | 0.00% | −10,136−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,101−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −394−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −279−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |